TuisAMGN • NASDAQ
add
Amgen Inc
Vorige sluiting
$264,21
Dagwisseling
$260,55 - $264,79
Jaarwisseling
$253,30 - $346,85
Markkapitalisasie
140,96 mjd USD
Gemiddelde volume
4,30 m
P/V-verhouding
33,55
Dividend-opbrengs
3,63%
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 8,50 mjd | 23,18% |
Bedryfskoste | 3,14 mjd | -2,61% |
Netto inkomste | 2,83 mjd | 63,58% |
Netto winsgrens | 33,28 | 32,80% |
Wins per aandeel | 5,58 | 12,50% |
EBITDA | 3,45 mjd | 24,59% |
Effektiewe belastingkoers | 8,74% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 9,01 mjd | -74,06% |
Totale bates | 90,88 mjd | 0,39% |
Totale aanspreeklikheid | 83,36 mjd | 0,58% |
Totale ekwiteit | 7,53 mjd | — |
Uitstaande aandele | 537,53 m | — |
Prys om te bespreek | 18,87 | — |
Opbrengs op bates | 5,65% | — |
Opbrengs op kapitaal | 7,52% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 2,83 mjd | 63,58% |
Kontant van bedrywe | 3,57 mjd | 29,38% |
Kontant van beleggings | -210,00 m | 19,85% |
Kontant van finansiering | -3,65 mjd | -82,09% |
Netto kontantverandering | -290,00 m | -158,82% |
Beskikbare kontantvloei | 2,87 mjd | 114,60% |
Meer oor
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. As one of the world's largest independent biotechnology companies, Amgen has approximately 24,000 staff in total as of 2022.
The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics, which became the official name of the company in 1983. The company is listed on the Nasdaq Global Select Market under the ticker symbol "AMGN", as well as a component of the Nasdaq-100, the Dow Jones Industrial Average, and the S&P 100 and 500 indices. Wikipedia
Gestig
08 Apr. 1980
Webwerf
Werknemers
26 700
